Fresenius Reports 5% Organic Revenue Growth in 3Q
Story updates
05:55:56 AM UTC
SquawkNews
Healthcare firm Fresenius Q3 revenue rises on Kabi growth; lifts outlook Overview Germany healthcare
Related stories
CTS Eventim Nine-Month Revenue Rises 8.1%, Reaffirms Outlook
CTS Eventim reported profitable growth in the first nine months of 2026, with gains in both business segments, and reaffirmed its full-year outlook.
M impact | EARNINGS | Nov 12, 2026, 08:21 PM UTC
CBOT soybeans end lower on profit taking, technical selling
CBOT soybeans end lower on profit taking, technical selling CHICAGO, Nov 12 (Reuters) - Chicago Boar
L impact | EARNINGS | Nov 12, 2026, 08:02 PM UTC
Table Trac Nine-Month Net Income More Than Doubles to $2.01 Million
Nine-month revenue rose 32% to $10.57 million.
M impact | EARNINGS | Nov 12, 2026, 07:51 PM UTC
ATI Targets Double-Digit Growth and Expanded Margins
ATI unveiled an acceleration strategy targeting double-digit growth and expanded margins.
M impact | EARNINGS | Nov 12, 2026, 07:42 PM UTC
Enel Nine-Month Net Profit Rises 9% to EUR 6.846 Billion
Enel reported nine-month 2026 revenue of EUR 65.022 billion, up 9% year over year, and operating profit of EUR 11.691 billion, up 7%.
M impact | EARNINGS | Nov 12, 2026, 07:31 PM UTC
DiaSorin 9-Month Net Profit Up, Despite Lower EBITDA
ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Thursday reported nine-month 2026 net profit of EUR 126 million, down 8 percent from EUR 137.1 million a year earlier.Revenue edged up
L impact | EARNINGS | Nov 12, 2026, 07:30 PM UTC